Published in Arterioscler Thromb Vasc Biol on November 01, 2011
An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med (2012) 2.59
VEGF-Induced Expression of miR-17-92 Cluster in Endothelial Cells Is Mediated by ERK/ELK1 Activation and Regulates Angiogenesis. Circ Res (2015) 1.52
Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One (2013) 1.48
Cell-based therapy for prevention and reversal of myocardial remodeling. Am J Physiol Heart Circ Physiol (2012) 1.31
A regulatory role for microRNA 33* in controlling lipid metabolism gene expression. Mol Cell Biol (2013) 1.21
MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia. Circ Res (2012) 1.19
Vascular endothelial cell-specific microRNA-15a inhibits angiogenesis in hindlimb ischemia. J Biol Chem (2012) 1.19
Urinary microRNA profiling in the nephropathy of type 1 diabetes. PLoS One (2013) 1.16
Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. Antioxid Redox Signal (2013) 1.15
MicroRNAs-role in lung cancer. Dis Markers (2014) 1.11
miR-1 and miR-206 regulate angiogenesis by modulating VegfA expression in zebrafish. Development (2012) 1.10
Urinary exosomal microRNAs in incipient diabetic nephropathy. PLoS One (2013) 1.10
The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma. PLoS One (2012) 1.04
MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression. Sci Rep (2014) 1.02
MicroRNA-503 and the extended microRNA-16 family in angiogenesis. Trends Cardiovasc Med (2011) 1.02
miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat. Cardiovasc Res (2013) 0.99
Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases. Front Cell Dev Biol (2014) 0.99
Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase. Exp Ther Med (2013) 0.98
MicroRNAs as pharmacological targets in endothelial cell function and dysfunction. Pharmacol Res (2013) 0.92
Key developments in stem cell therapy in cardiology. Regen Med (2012) 0.92
Circulating microRNAs serve as novel biological markers for intracranial aneurysms. J Am Heart Assoc (2014) 0.91
MicroRNAs: promising new antiangiogenic targets in cancer. Biomed Res Int (2014) 0.91
Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model. Sci Rep (2013) 0.91
The unique expression and function of miR-424 in human placental trophoblasts. Biol Reprod (2013) 0.91
TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation. Cancer Res (2015) 0.90
Simultaneously expressed miR-424 and miR-381 synergistically suppress the proliferation and survival of renal cancer cells---Cdc2 activity is up-regulated by targeting WEE1. Clinics (Sao Paulo) (2013) 0.90
MicroRNA control of vascular endothelial growth factor signaling output during vascular development. Arterioscler Thromb Vasc Biol (2013) 0.90
MicroRNAs and atherosclerosis. Curr Atheroscler Rep (2013) 0.89
Angiogenesis-regulating microRNAs and Ischemic Stroke. Curr Vasc Pharmacol (2015) 0.89
MicroRNAs in Vascular Biology. Int J Vasc Med (2012) 0.89
Altered expression of circulating microRNA in plasma of patients with primary osteoarthritis and in silico analysis of their pathways. PLoS One (2014) 0.88
Mirtron microRNA-1236 inhibits VEGFR-3 signaling during inflammatory lymphangiogenesis. Arterioscler Thromb Vasc Biol (2012) 0.88
Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death. Cell Death Dis (2014) 0.88
Autoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in human endothelial cells. J Cell Sci (2014) 0.87
Hypoxia inducible factor-1 mediates expression of miR-322: potential role in proliferation and migration of pulmonary arterial smooth muscle cells. Sci Rep (2015) 0.87
microRNAs 424 and 503 are mediators of the anti-proliferative and anti-invasive action of the thyroid hormone receptor beta. Oncotarget (2014) 0.86
MicroRNAs as regulators of endothelial cell functions in cardiometabolic diseases. Biochim Biophys Acta (2016) 0.84
AIP1 mediates vascular endothelial cell growth factor receptor-3-dependent angiogenic and lymphangiogenic responses. Arterioscler Thromb Vasc Biol (2014) 0.84
The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon. J Transl Med (2012) 0.83
Improved repair of dermal wounds in mice lacking microRNA-155. J Cell Mol Med (2014) 0.83
Identification of a new target of miR-16, Vacuolar Protein Sorting 4a. PLoS One (2014) 0.82
MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1. Oncogene (2016) 0.80
Peritoneal fluid reduces angiogenesis-related microRNA expression in cell cultures of endometrial and endometriotic tissues from women with endometriosis. PLoS One (2013) 0.80
Fibroblast Growth Factor Signaling Mediates Pulmonary Endothelial Glycocalyx Reconstitution. Am J Respir Cell Mol Biol (2017) 0.80
Hypoxia alters MicroRNA expression in rat cortical pericytes. Microrna (2013) 0.79
MicroRNAs as potential therapeutics for treating spinal cord injury. Neural Regen Res (2012) 0.78
Maternal protein restriction alters VEGF signaling and decreases pulmonary alveolar in fetal rats. Int J Clin Exp Pathol (2014) 0.78
The evolving roles of pericyte in early brain injury after subarachnoid hemorrhage. Brain Res (2015) 0.78
Mechanisms and therapeutic potential of microRNAs in hypertension. Drug Discov Today (2015) 0.78
Antiangiogenic role of miR-361 in human umbilical vein endothelial cells: functional interaction with the peptide somatostatin. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.77
Altered miRNA expression in pulmonary sarcoidosis. BMC Med Genet (2016) 0.77
Cancer stem cells and exosome signaling. Stem Cell Investig (2015) 0.76
PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach. Oncotarget (2016) 0.75
Acute Effects of Different Exercise Protocols on the Circulating Vascular microRNAs -16, -21, and -126 in Trained Subjects. Front Physiol (2016) 0.75
MicroRNAs looping around angiogenesis. Arterioscler Thromb Vasc Biol (2011) 0.75
The CUL3-SPOP-DAXX axis is a novel regulator of VEGFR2 expression in vascular endothelial cells. Sci Rep (2017) 0.75
Role of stem cell-derived exosomes in cancer. Oncol Lett (2017) 0.75
Acute Response of Circulating Vascular Regulating MicroRNAs during and after High-Intensity and High-Volume Cycling in Children. Front Physiol (2016) 0.75
Upregulation of Mir-21 Levels in the Vitreous Humor Is Associated with Development of Proliferative Vitreoretinal Disease. PLoS One (2016) 0.75
Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease. Curr Vasc Pharmacol (2013) 0.75
A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs. BMC Vet Res (2016) 0.75
The expression and function of miR-424 in infantile skin hemangioma and its mechanism. Sci Rep (2017) 0.75
Modulation of miR29a improves impaired post-ischemic angiogenesis in hyperglycemia. Exp Biol Med (Maywood) (2017) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A (2005) 21.51
Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (1989) 16.71
microRNA functions. Annu Rev Cell Dev Biol (2007) 15.74
Angiogenesis in life, disease and medicine. Nature (2005) 15.36
VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol (2006) 12.09
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem (1998) 8.30
Autocrine VEGF signaling is required for vascular homeostasis. Cell (2007) 7.37
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell (2008) 7.26
MiR-33 contributes to the regulation of cholesterol homeostasis. Science (2010) 6.93
miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell (2008) 6.59
Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol (2007) 6.43
MicroRNA control of signal transduction. Nat Rev Mol Cell Biol (2010) 5.74
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med (2008) 5.74
Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res (2007) 5.09
Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res (2007) 4.72
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev (2005) 4.65
Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem (2004) 4.40
MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One (2006) 4.29
Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol (2001) 3.84
Lost in translation: an assessment and perspective for computational microRNA target identification. Bioinformatics (2009) 3.34
miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res (2008) 3.19
Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A (2008) 3.03
Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood (2010) 2.80
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther (2011) 2.75
In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci U S A (2000) 2.67
Lysophospholipids--receptor revelations. Science (2001) 2.61
miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell (2008) 2.57
MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology (2009) 2.57
Retracted Maturation of microRNA is hormonally regulated by a nuclear receptor. Mol Cell (2009) 2.48
Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc Natl Acad Sci U S A (2010) 2.47
miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res (2009) 2.39
MicroRNAs as novel regulators of angiogenesis. Circ Res (2009) 2.33
Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis. J Clin Invest (2010) 2.32
MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol (2008) 2.16
Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res (2000) 2.12
microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol (2010) 2.06
Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol (2009) 1.93
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene (2011) 1.69
MicroRNAs: opening a new vein in angiogenesis research. Sci Signal (2009) 1.58
Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost (1997) 1.56
Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol (2000) 1.38
MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. J Biol Chem (2009) 1.30
Vascularization and engraftment of a human skin substitute using circulating progenitor cell-derived endothelial cells. FASEB J (2006) 1.25
What is the role of endothelial cells in angiogenesis? Lab Invest (1984) 1.11
Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy. PLoS One (2010) 1.09
microRNAs expression in endometriosis and their relation to angiogenic factors. Hum Reprod (2011) 1.08
Alloimmunity to human endothelial cells derived from cord blood progenitors. J Immunol (2007) 1.06
MiR-33 contributes to the regulation of cholesterol homeostasis. Science (2010) 6.93
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature (2011) 5.78
A compendium of RNA-binding motifs for decoding gene regulation. Nature (2013) 4.91
Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res (2007) 4.72
Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol Syst Biol (2010) 3.56
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A (2011) 3.35
Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A (2008) 3.03
Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab (2007) 2.53
The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO. Cell (2012) 2.25
MicroRNAs in lipid metabolism. Curr Opin Lipidol (2011) 1.79
Nogo-B receptor stabilizes Niemann-Pick type C2 protein and regulates intracellular cholesterol trafficking. Cell Metab (2009) 1.76
Notch pathway activation targets AML-initiating cell homeostasis and differentiation. J Exp Med (2013) 1.71
Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle (2012) 1.60
Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line. Biochem J (2009) 1.55
MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol (2011) 1.54
Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats. Gut (2012) 1.53
microRNAs and cholesterol metabolism. Trends Endocrinol Metab (2010) 1.49
Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. Proc Natl Acad Sci U S A (2009) 1.46
Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis. Cell Metab (2009) 1.44
Site identification in high-throughput RNA-protein interaction data. Bioinformatics (2012) 1.43
MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression. Exp Neurol (2011) 1.38
Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function. PLoS One (2011) 1.33
MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol (2013) 1.33
The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu Rev Nutr (2011) 1.30
Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes. J Biol Chem (2009) 1.29
Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report. Arterioscler Thromb Vasc Biol (2013) 1.28
Reticulon 4B (Nogo-B) is necessary for macrophage infiltration and tissue repair. Proc Natl Acad Sci U S A (2009) 1.27
Nontelomeric role for Rap1 in regulating metabolism and protecting against obesity. Cell Rep (2013) 1.25
Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144. Circ Res (2013) 1.25
Genomic analyses of the RNA-binding protein Hu antigen R (HuR) identify a complex network of target genes and novel characteristics of its binding sites. J Biol Chem (2011) 1.24
Before It Gets Started: Regulating Translation at the 5' UTR. Comp Funct Genomics (2012) 1.22
A regulatory role for microRNA 33* in controlling lipid metabolism gene expression. Mol Cell Biol (2013) 1.21
Vitamin D regulates the phenotype of human breast cancer cells. Differentiation (2006) 1.20
MicroRNA 33 regulates glucose metabolism. Mol Cell Biol (2013) 1.19
Post-transcription meets post-genomic: the saga of RNA binding proteins in a new era. RNA Biol (2006) 1.18
Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122. J Biol Chem (2011) 1.11
miR-1 and miR-206 regulate angiogenesis by modulating VegfA expression in zebrafish. Development (2012) 1.10
ATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase. Arterioscler Thromb Vasc Biol (2010) 1.10
JNK activation is critical for Aplidin-induced apoptosis. Oncogene (2004) 1.08
Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy. BMC Cancer (2008) 1.04
MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice. PLoS One (2013) 1.04
The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells. Mol Cancer Res (2012) 1.02
VEGF-independent cell-autonomous functions of HIF-1α regulating oxygen consumption in fetal cartilage are critical for chondrocyte survival. J Bone Miner Res (2012) 1.00
Regulation of cholesterol homeostasis. Cell Mol Life Sci (2011) 1.00
The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis. Am J Pathol (2012) 0.98
Quantitative proteomics of caveolin-1-regulated proteins: characterization of polymerase i and transcript release factor/CAVIN-1 IN endothelial cells. Mol Cell Proteomics (2010) 0.98
The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs. RNA Biol (2011) 0.98
MicroRNAs as pharmacological targets in endothelial cell function and dysfunction. Pharmacol Res (2013) 0.92
Dietary lipids modulate the expression of miR-107, an miRNA that regulates the circadian system. Mol Nutr Food Res (2015) 0.92
Translation regulation gets its 'omics' moment. Wiley Interdiscip Rev RNA (2013) 0.92
Lack of HIF-2α in limb bud mesenchyme causes a modest and transient delay of endochondral bone development. Nat Med (2011) 0.92
A comprehensive in silico expression analysis of RNA binding proteins in normal and tumor tissue: Identification of potential players in tumor formation. RNA Biol (2009) 0.91
MicroRNAs and lipoproteins: a connection beyond atherosclerosis? Atherosclerosis (2012) 0.90
Musashi1: an RBP with versatile functions in normal and cancer stem cells. Front Biosci (Landmark Ed) (2012) 0.90
MicroRNAs and atherosclerosis. Curr Atheroscler Rep (2013) 0.89
Red grape juice polyphenols alter cholesterol homeostasis and increase LDL-receptor activity in human cells in vitro. J Nutr (2006) 0.89
MicroRNA Regulation of Cholesterol Metabolism. Cholesterol (2012) 0.88
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases. Free Radic Biol Med (2013) 0.88
Inhibition of cholesterol biosynthesis by Delta22-unsaturated phytosterols via competitive inhibition of sterol Delta24-reductase in mammalian cells. Biochem J (2002) 0.88
Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer. Oncotarget (2013) 0.87
Autoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in human endothelial cells. J Cell Sci (2014) 0.87
"Micromanaging" metabolic syndrome. Cell Cycle (2011) 0.86
Proteomic analysis of the resistance to aplidin in human cancer cells. J Proteome Res (2007) 0.85
Lovastatin-induced PC-12 cell differentiation is associated with RhoA/RhoA kinase pathway inactivation. Mol Cell Neurosci (2005) 0.83
Improved repair of dermal wounds in mice lacking microRNA-155. J Cell Mol Med (2014) 0.83
microRNA regulation of lipoprotein metabolism. Curr Opin Lipidol (2014) 0.82
Relevance of microRNA in metabolic diseases. Crit Rev Clin Lab Sci (2014) 0.82
Impaired liver regeneration in Ldlr-/- mice is associated with an altered hepatic profile of cytokines, growth factors, and lipids. J Hepatol (2013) 0.82
Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease. Curr Vasc Pharmacol (2015) 0.81
Computational challenges, tools, and resources for analyzing co- and post-transcriptional events in high throughput. Wiley Interdiscip Rev RNA (2014) 0.81
Over-represented sequences located on 3' UTRs are potentially involved in regulatory functions. RNA Biol (2008) 0.81
Cholesterol starvation induces differentiation of human leukemia HL-60 cells. Cancer Res (2007) 0.81
Curcumin promotes exosomes/microvesicles secretion that attenuates lysosomal cholesterol traffic impairment. Mol Nutr Food Res (2013) 0.80
Emerging role of microRNAs in the regulation of lipid metabolism. Hepatology (2013) 0.79
From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport. Pharmacol Res (2013) 0.78
New insights into microRNA-29 regulation: a new key player in cardiovascular disease. J Mol Cell Cardiol (2012) 0.77
Microregulation of plaque neovascularization. Arterioscler Thromb Vasc Biol (2010) 0.77
The RNA-Binding Protein Musashi1: A Major Player in Intestinal Epithelium Renewal and Colon Cancer Development. Curr Colorectal Cancer Rep (2012) 0.76
Truths and controversies concerning the role of miRNAs in atherosclerosis and lipid metabolism. Curr Opin Lipidol (2016) 0.76
MiRNA-based therapy: from bench to bedside. Pharmacol Res (2013) 0.75
LATENT RANK CHANGE DETECTION FOR ANALYSIS OF SPLICE-JUNCTION MICROARRAYS WITH NONLINEAR EFFECTS. Ann Appl Stat (2011) 0.75
MicroRNAs and lipid metabolism. Curr Opin Lipidol (2017) 0.75